Skip to main content

PFM Health Sciences, LP

13F filer · CIK 0001442756
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$1.17BU.S. long equity reported on 13F
Positions9632 new · 12 closed
Net flow last quarter-$2.1MBuys minus sells
Top 10 positions weight33.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202696 positions
ASNDAscendis Pharma A/S$62.2M5.34%0.38%+53.4%Q4 2018
AXSMAxsome Therapeutics, Inc.$53.8M4.61%0.42%-16.9%Q2 2022
LLYELI LILLY & Co$47.1M4.04%0.00%-40.3%Q3 2015
JAZZJazz Pharmaceuticals plc$38.7M3.32%0.26%-9.8%Q1 2015
HUMHumana Inc$37.5M3.22%0.08%Not reportedQ3 2013
UNHUnitedhealth Group Inc$36.7M3.15%0.01%+52.1%Q4 2014
NBIXNeurocrine Biosciences Inc$36M3.09%0.21%-1.1%Q1 2021
INBXInhibrx Biosciences, Inc.$29.2M2.51%2.10%+1.0%Q1 2023
UTHRUNITED THERAPEUTICS Corp$27.1M2.32%0.12%+25.6%Q4 2024
RVMDRevolution Medicines, Inc.$26.8M2.30%0.07%+1.7%Q3 2020
ICLRIcon PLC$23.7M2.03%0.18%+137.4%Q3 2016
THCTenet Healthcare Corp$23.7M2.03%0.15%-68.2%Q3 2013
EWEdwards Lifesciences Corp$22.7M1.94%0.04%-1.6%Q4 2014
WATWaters Corp$22.4M1.93%0.06%+50.5%Q2 2013
PENPenumbra Inc$19M1.63%0.15%-56.9%Q3 2015
BBIOBridgeBio Pharma, Inc.$18.9M1.62%0.13%-1.7%Q4 2024
SYKStryker Corp$17.8M1.53%0.01%+158.0%Q4 2014
MTDMettler Toledo International Inc/$17M1.46%0.07%Not reportedQ4 2016
INDVIndivior Pharmaceuticals, Inc.$16.5M1.41%0.33%-30.2%Q1 2025
MRKMerck & Co., Inc.$16.3M1.40%0.01%Not reportedQ2 2013
CYTKCytokinetics Inc$16.3M1.40%0.15%Not reportedQ4 2020
LNTHLantheus Holdings, Inc.$16.2M1.39%0.22%Not reportedQ3 2023
CNCCentene Corp$16M1.37%0.05%-5.6%Q3 2014
COOCooper Companies, Inc.$15.8M1.36%0.11%+30.1%Q2 2013
MDGLMadrigal Pharmaceuticals, Inc.$15.7M1.35%0.13%-14.2%Q1 2021
ACHCAcadia Healthcare Company, Inc.$15.5M1.33%0.58%-9.9%Q2 2015
ORKAOruka Therapeutics, Inc.$15.1M1.30%0.26%-8.8%Q1 2026
OSCROscar Health, Inc.$14.8M1.27%Not reported+3.8%Q2 2023
TMOThermo Fisher Scientific Inc.$14.3M1.23%0.01%+92.1%Q2 2013
CVSCVS HEALTH Corp$14.2M1.22%0.01%Not reportedQ1 2025
MMSIMerit Medical Systems Inc$13.7M1.17%0.33%+21.3%Q2 2017
PRAXPraxis Precision Medicines, Inc.$12.9M1.11%0.14%+8.9%Q2 2021
CLDXCelldex Therapeutics, Inc.$12.8M1.09%0.44%+5.5%Q4 2023
NVONovo Nordisk A S$12.7M1.09%Not reported+34.4%Q1 2026
ITGRInteger Holdings Corp$11.8M1.02%0.37%-6.2%Q4 2025
DNTHDianthus Therapeutics, Inc.$11.8M1.01%0.22%-29.6%Q3 2025
DFTXDefinium Therapeutics, Inc.$11.7M1.01%0.19%+21.3%Q1 2026
GILDGilead Sciences, Inc.$11.5M0.98%0.01%Not reportedQ1 2013
RYTMRhythm Pharmaceuticals, Inc.$11.3M0.97%0.15%-25.7%Q3 2025
HSICHenry Schein Inc$11.2M0.96%0.12%-12.2%Q3 2020
ARWRArrowhead Pharmaceuticals, Inc.$10.7M0.92%0.09%+104.8%Q1 2026
TNGXTango Therapeutics, Inc.$10.2M0.87%0.19%-19.7%Q1 2026
TFXTeleflex Inc$10.1M0.87%0.18%Not reportedQ1 2018
VKTXViking Therapeutics, Inc.$9.96M0.85%0.22%-3.0%Q1 2024
BTSGBrightSpring Health Services, Inc.$9.9M0.85%0.07%-24.3%Q4 2025
VERAVera Therapeutics, Inc.$9.62M0.83%0.31%+28.3%Q3 2025
ROIVRoivant Sciences Ltd.$9.48M0.81%0.04%+29.2%Q2 2023
CGONCG Oncology, Inc.$9.11M0.78%0.15%-22.7%Q3 2025
AMRXAmneal Pharmaceuticals, Inc.$8.32M0.71%0.15%-48.3%Q3 2025
EPRXEupraxia Pharmaceuticals Inc.$8M0.69%2.33%+123.8%Q1 2026
Q1 2026Reported May 15, 202676 positions
THCTenet Healthcare Corp$75.2M6.86%0.46%+0.2%Q3 2013
LLYELI LILLY & Co$60.5M5.52%0.01%-3.7%Q3 2015
PENPenumbra Inc$45.9M4.19%0.36%-3.7%Q3 2015
AXSMAxsome Therapeutics, Inc.$44.7M4.07%0.51%+5.1%Q2 2022
ASNDAscendis Pharma A/S$34.8M3.17%0.25%-14.4%Q4 2018
JAZZJazz Pharmaceuticals plc$33.7M3.07%0.29%+252.7%Q1 2015
NBIXNeurocrine Biosciences Inc$28.4M2.59%0.21%+32.2%Q1 2021
UTHRUNITED THERAPEUTICS Corp$23.6M2.15%0.09%-41.2%Q4 2024
GKOSGLAUKOS Corp$23.2M2.12%0.37%+7.0%Q4 2025
CNTACentessa Pharmaceuticals PLC$21M1.91%0.34%-10.7%Q1 2024
INBXInhibrx Biosciences, Inc.$20.5M1.87%2.09%+15.0%Q1 2023
EWEdwards Lifesciences Corp$20.4M1.86%0.04%+3.1%Q4 2014
BBIOBridgeBio Pharma, Inc.$19.1M1.75%0.13%-15.9%Q4 2024
MDGLMadrigal Pharmaceuticals, Inc.$17.9M1.63%0.15%+370.5%Q1 2021
INDVIndivior Pharmaceuticals, Inc.$17.5M1.60%0.46%+59.3%Q1 2025
UNHUnitedhealth Group Inc$15.7M1.43%0.01%+14.8%Q4 2014
DNTHDianthus Therapeutics, Inc.$14.4M1.32%0.32%+72.9%Q3 2025
ABTAbbott Laboratories$14.4M1.31%0.01%Not reportedQ2 2017
RVMDRevolution Medicines, Inc.$13.7M1.25%0.07%-7.1%Q3 2020
ACHCAcadia Healthcare Company, Inc.$13.6M1.24%0.64%Not reportedQ2 2015
NEONeogenomics Inc$13.2M1.21%1.38%+5.3%Q1 2025
COOCooper Companies, Inc.$12.1M1.11%0.09%+68.5%Q2 2013
NTRANatera, Inc.$12M1.09%0.04%Not reportedQ2 2025
ITGRInteger Holdings Corp$11.9M1.08%0.39%+26.7%Q4 2025
RYTMRhythm Pharmaceuticals, Inc.$11.9M1.08%0.20%+239.8%Q3 2025
WATWaters Corp$11.8M1.08%0.04%-8.0%Q2 2013
AMRXAmneal Pharmaceuticals, Inc.$11.6M1.05%0.30%-36.5%Q3 2025
PRAXPraxis Precision Medicines, Inc.$11.4M1.04%0.13%+13.7%Q2 2021
HSICHenry Schein Inc$11.3M1.03%0.13%Not reportedQ3 2020
CGONCG Oncology, Inc.$11.2M1.02%0.19%+1.2%Q3 2025
MMSIMerit Medical Systems Inc$11.2M1.02%0.27%Not reportedQ2 2017
CLDXCelldex Therapeutics, Inc.$10.3M0.94%0.49%+144.0%Q4 2023
BLTEBelite Bio, Inc$9.48M0.86%0.15%+199.8%Q4 2025
DXCMDexcom Inc$9.4M0.86%0.04%-34.1%Q4 2015
TERNTerns Pharmaceuticals, Inc.$9.12M0.83%0.15%Not reportedQ1 2021
CNCCentene Corp$8.63M0.79%0.05%-63.7%Q3 2014
VKTXViking Therapeutics, Inc.$8.56M0.78%0.23%+39.2%Q1 2024
ORKAOruka Therapeutics, Inc.$8.54M0.78%0.35%NewQ1 2026
TNGXTango Therapeutics, Inc.$8.5M0.77%0.28%NewQ1 2026
SLNOSoleno Therapeutics Inc$8.31M0.76%0.48%+0.1%Q4 2024
BTSGBrightSpring Health Services, Inc.$7.98M0.73%0.10%+58.1%Q4 2025
CMPSCOMPASS Pathways plc$7.56M0.69%1.01%+75.4%Q2 2022
TMOThermo Fisher Scientific Inc.$7.29M0.66%0.00%-60.9%Q2 2013
NVONovo Nordisk A S$7.25M0.66%Not reportedNewQ1 2026
SYKStryker Corp$7.21M0.66%0.01%-56.8%Q4 2014
VERAVera Therapeutics, Inc.$7.03M0.64%0.27%+62.4%Q3 2025
BLLNBillionToOne, Inc.$6.95M0.63%0.79%+0.6%Q4 2025
CAHCardinal Health Inc$6.75M0.62%0.01%-48.8%Q3 2014
ICLRIcon PLC$6.36M0.58%0.08%-50.2%Q3 2016
ALHCAlignment Healthcare, Inc.$6.34M0.58%0.17%NewQ1 2026
Q4 2025Reported Feb 17, 202676 positions
THCTenet Healthcare Corp$79M7.88%0.45%-13.8%Q3 2013
LLYELI LILLY & Co$73.4M7.32%0.01%-69.7%Q3 2015
AXSMAxsome Therapeutics, Inc.$45.9M4.58%0.49%-52.6%Q2 2022
PENPenumbra Inc$45.1M4.50%0.37%-25.6%Q3 2015
ASNDAscendis Pharma A/S$37.9M3.78%0.29%+22.3%Q4 2018
UTHRUNITED THERAPEUTICS Corp$33M3.29%0.16%-29.2%Q4 2024
CNCCentene Corp$29.9M2.98%0.15%+26.3%Q3 2014
BBIOBridgeBio Pharma, Inc.$23.4M2.34%0.16%-6.3%Q4 2024
ADMAAdma Biologics, Inc.$23.2M2.31%0.53%+7.6%Q3 2025
NBIXNeurocrine Biosciences Inc$23.1M2.31%0.16%+185.1%Q1 2021
GKOSGLAUKOS Corp$22.8M2.27%0.35%NewQ4 2025
TMOThermo Fisher Scientific Inc.$22M2.19%0.01%+1538.5%Q2 2013
EWEdwards Lifesciences Corp$21M2.10%0.04%-35.3%Q4 2014
ICLRIcon PLC$21M2.10%0.15%-13.7%Q3 2016
INBXInhibrx Biosciences, Inc.$21M2.09%1.82%+10.8%Q1 2023
MDTMedtronic plc$20.5M2.05%0.02%NewQ4 2025
NEONeogenomics Inc$19.9M1.99%1.31%-23.3%Q1 2025
MRKMerck & Co., Inc.$19.8M1.97%0.01%-20.6%Q2 2013
AMRXAmneal Pharmaceuticals, Inc.$18.5M1.84%0.47%+311.9%Q3 2025
SYKStryker Corp$17.9M1.78%0.01%Not reportedQ4 2014
UNHUnitedhealth Group Inc$16.7M1.66%0.01%Not reportedQ4 2014
WATWaters Corp$16.4M1.64%0.07%+40.5%Q2 2013
DXCMDexcom Inc$15.1M1.50%0.06%Not reportedQ4 2015
CNTACentessa Pharmaceuticals PLC$14.8M1.48%0.40%-11.2%Q1 2024
INDVIndivior Pharmaceuticals, Inc.$12.9M1.29%0.29%-35.8%Q1 2025
CAHCardinal Health Inc$12.8M1.28%0.03%Not reportedQ3 2014
UHSUniversal Health Services Inc$12.5M1.25%Not reported-50.6%Q1 2013
TFXTeleflex Inc$12.5M1.25%0.23%Not reportedQ1 2018
RVMDRevolution Medicines, Inc.$12.1M1.20%0.08%-54.3%Q3 2020
SLNOSoleno Therapeutics Inc$11.5M1.14%0.47%+1.9%Q4 2024
PRAXPraxis Precision Medicines, Inc.$9.18M0.92%0.12%-48.6%Q2 2021
ISRGIntuitive Surgical Inc$8.73M0.87%0.00%-80.1%Q2 2018
GILDGilead Sciences, Inc.$8.72M0.87%0.01%Not reportedQ1 2013
JAZZJazz Pharmaceuticals plc$8.59M0.86%0.08%Not reportedQ1 2015
CVSCVS HEALTH Corp$8.55M0.85%0.01%-68.9%Q1 2025
SNYSanofi$8.55M0.85%0.01%NewQ4 2025
IQVIqvia Holdings Inc.$8.53M0.85%0.02%Not reportedQ1 2019
ITGRInteger Holdings Corp$8.36M0.83%0.31%NewQ4 2025
COOCooper Companies, Inc.$8.26M0.82%0.05%+35.6%Q2 2013
VEEVVeeva Systems Inc$7.25M0.72%0.02%-21.7%Q2 2022
OSCROscar Health, Inc.$7.18M0.72%Not reported-39.1%Q2 2023
BLLNBillionToOne, Inc.$7.16M0.71%0.78%NewQ4 2025
CGONCG Oncology, Inc.$6.81M0.68%0.20%+3.9%Q3 2025
VKTXViking Therapeutics, Inc.$6.65M0.66%0.16%+3.0%Q1 2024
ALGNAlign Technology Inc$6.61M0.66%0.06%Not reportedQ1 2013
HCAHCA Healthcare, Inc.$6.47M0.65%0.01%-78.9%Q1 2013
PSNLPersonalis, Inc.$6.41M0.64%0.79%NewQ4 2025
VERAVera Therapeutics, Inc.$5.45M0.54%0.17%-79.0%Q3 2025
CMPSCOMPASS Pathways plc$5.38M0.54%0.81%-53.1%Q2 2022
SNDXSyndax Pharmaceuticals Inc$5.1M0.51%0.28%-5.3%Q1 2021
Q3 2025Reported Nov 14, 202566 positions
LLYELI LILLY & Co$172M13.21%0.02%-16.0%Q3 2015
THCTenet Healthcare Corp$93.7M7.21%0.52%-7.5%Q3 2013
AXSMAxsome Therapeutics, Inc.$64.4M4.95%1.05%+9.8%Q2 2022
MCKMckesson Corp$55.9M4.30%0.06%Not reportedQ3 2013
PENPenumbra Inc$49.4M3.80%0.50%+17.3%Q3 2015
UTHRUNITED THERAPEUTICS Corp$40.1M3.08%0.22%+162.8%Q4 2024
ISRGIntuitive Surgical Inc$34.6M2.66%0.02%-13.0%Q2 2018
EWEdwards Lifesciences Corp$29.7M2.28%0.07%-2.9%Q4 2014
ASNDAscendis Pharma A/S$28.9M2.22%0.24%-34.5%Q4 2018
HCAHCA Healthcare, Inc.$28M2.16%0.03%-9.0%Q1 2013
CVSCVS HEALTH Corp$26.1M2.01%0.03%-27.6%Q1 2025
CORCencora, Inc.$25.2M1.93%0.04%+51.1%Q1 2020
OMOutset Medical, Inc.$24.4M1.88%9.71%+3.9%Q3 2020
UHSUniversal Health Services Inc$23.8M1.83%Not reportedNot reportedQ1 2013
ICLRIcon PLC$23.4M1.80%0.18%+51.6%Q3 2016
CNCCentene Corp$20.5M1.58%0.12%Not reportedQ3 2014
MRKMerck & Co., Inc.$19.8M1.53%0.01%Not reportedQ2 2013
ELVElevance Health, Inc.$19.6M1.51%0.03%Not reportedQ2 2015
NTRANatera, Inc.$18.6M1.43%0.08%+14.2%Q2 2025
ADMAAdma Biologics, Inc.$17.3M1.33%0.50%NewQ3 2025
NEONeogenomics Inc$17M1.31%1.71%+186.8%Q1 2025
BBIOBridgeBio Pharma, Inc.$17M1.31%0.17%-37.3%Q4 2024
SLNOSoleno Therapeutics Inc$16.5M1.27%0.45%-40.2%Q4 2024
CNTACentessa Pharmaceuticals PLC$16.2M1.24%0.50%+93.1%Q1 2024
OSCROscar Health, Inc.$15.5M1.19%Not reported+11.7%Q2 2023
RVMDRevolution Medicines, Inc.$15.5M1.19%0.17%Not reportedQ3 2020
VERAVera Therapeutics, Inc.$14.9M1.15%0.80%NewQ3 2025
SPYSPDR S&P 500 ETF Trust$14.1M1.09%Not reported+23.8%Q3 2017
INDVIndivior Pharmaceuticals, Inc.$13.5M1.04%0.45%-58.6%Q1 2025
VEEVVeeva Systems Inc$12.4M0.95%0.03%Not reportedQ2 2022
MRUSMerus N.V.$12.3M0.95%0.17%-28.9%Q2 2025
AKROAkero Therapeutics, Inc.$11.8M0.91%0.31%-6.8%Q3 2023
REGNRegeneron Pharmaceuticals, Inc.$11.2M0.86%0.02%Not reportedQ1 2013
IRTCiRhythm Holdings, Inc.$11.2M0.86%0.20%-26.3%Q2 2018
CMPSCOMPASS Pathways plc$9.53M0.73%1.73%-6.5%Q2 2022
WATWaters Corp$9.22M0.71%0.05%-28.6%Q2 2013
VRNAVerona Pharma plc$8.58M0.66%0.01%Not reportedQ2 2025
INBXInhibrx Biosciences, Inc.$8.07M0.62%1.65%-1.9%Q1 2023
NBIXNeurocrine Biosciences Inc$8.04M0.62%0.06%+346.5%Q1 2021
TEVATeva Pharmaceutical Industries Ltd$7.21M0.55%0.03%-71.2%Q1 2014
ARQTArcutis Biotherapeutics, Inc.$6.79M0.52%0.30%-61.0%Q2 2025
CGONCG Oncology, Inc.$6.36M0.49%0.20%NewQ3 2025
AMLXAmylyx Pharmaceuticals, Inc.$5.93M0.46%0.40%-40.4%Q1 2025
COOCooper Companies, Inc.$5.1M0.39%0.04%Not reportedQ2 2013
RYTMRhythm Pharmaceuticals, Inc.$4.86M0.37%0.07%NewQ3 2025
VKTXViking Therapeutics, Inc.$4.82M0.37%0.16%+386.5%Q1 2024
WSTWest Pharmaceutical Services Inc$4.82M0.37%0.03%Not reportedQ1 2024
AZNAstrazeneca PLC$4.74M0.36%Not reportedNot reportedQ2 2020
ARGXArgenx SE$4.72M0.36%0.01%-11.5%Q4 2018
RZLTRezolute, Inc.$4.26M0.33%0.50%+4.3%Q2 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.